💊 unlocking synthetic lethality: targeting parp inhibition in brca1 and brca2 mutant cancers 🛑
Published 4 years ago • 5K plays • Length 9:20Download video MP4
Download video MP3
Similar videos
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
3:24
dr. jeffrey weitzel on synthetic lethality in brca-associated cancer
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
0:54
parp inhibitors advance beyond treatment of brca1/2-mutant gynecologic cancers
-
5:19
mechanisms of parp inhibition: a mode of targeted cancer treatment
-
3:56
parp inhibitors: activity in brca1 versus brca2 altered mcrpc
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
47:27
parp inhibitors: a breakthrough in cancer therapy?
-
1:58
discussing targeted treatment with parp inhibitors for brca-mutant patients across tumor types
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
3:31
distinguishing between parp inhibitors in breast cancer
-
2:21
profiling of brca mutations in colorectal cancer
-
11:49
brca & parp inhibitors: targeted chemotherapy | #markscholzmd #alexscholz @pcri
-
0:27
parp inhibitors #short
-
6:21
parp inhibition in brca1/2 or hrd- ovarian cancer
-
2:30
dr. birrer on parp inhibitors in ovarian cancer
-
0:25
banu arun, md, on parp inhibitors in brca positive metastatic breast cancer
-
22:27
parp and dna repair defects (brca mutations) - karen e. knudsen
-
1:17
dr. traina on parp inhibition in brca-mutated breast cancer